Moreover, a study revealed that the level of CYLD expression in acquired cholesteatoma is significantly correlated with the clinicopathological characteristics, including wound healing, infection, and recurrence in cholesteatoma patients (Miyake et al., 2020). The gene discussed is CYLD; the disease is cholesteatoma.